Anika Therapeutics, Inc. ( ANIK) - Key Metrics
ANIK Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q3 | $2.29 | -$0.02 | $0.63 | $0.50 |
| 2026Q2 | $2.43 | $0.25 | -$0.05 | -$0.16 |
| 2026Q1 | $2.19 | -$0.37 | -$0.36 | -$0.46 |
| 2025Q4 | $2.14 | $0.02 | $0.32 | $0.28 |
| 2025Q3 | $1.93 | -$0.16 | $0.48 | $0.35 |
ANIK Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q3 | 0% | -245.75 |
| 2026Q2 | 0% | 15.24 |
| 2026Q1 | 0% | -9.80 |
| 2025Q4 | 0% | 117.20 |
| 2025Q3 | 0% | -14.69 |
ANIK Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q3 | 2.55% | 0% |
| 2026Q2 | -1.09% | 0% |
| 2026Q1 | -3.20% | 0% |
| 2025Q4 | 2.91% | 0% |
| 2025Q3 | 3.68% | 0% |
ANIK
Price: $13.40
52 week price:
Earnings Per Share: -0.03 USD
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 53407
Ebitda: 11.5 millionMarket Capitalization: 185.0 million